BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18324929)

  • 41. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
    Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
    Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment.
    Schrauwen P; Mensink M; Schaart G; Moonen-Kornips E; Sels JP; Blaak EE; Russell AP; Hesselink MK
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1520-5. PubMed ID: 16384852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo.
    Bogacka I; Xie H; Bray GA; Smith SR
    Diabetes Care; 2004 Jul; 27(7):1660-7. PubMed ID: 15220243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin Sensitivity in Adipose and Skeletal Muscle Tissue of Dairy Cows in Response to Dietary Energy Level and 2,4-Thiazolidinedione (TZD).
    Hosseini A; Tariq MR; Trindade da Rosa F; Kesser J; Iqbal Z; Mora O; Sauerwein H; Drackley JK; Trevisi E; Loor JJ
    PLoS One; 2015; 10(11):e0142633. PubMed ID: 26571137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone.
    Unal R; Yao-Borengasser A; Varma V; Rasouli N; Labbate C; Kern PA; Ranganathan G
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2993-3001. PubMed ID: 20392866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity.
    Vitkova M; Klimcakova E; Kovacikova M; Valle C; Moro C; Polak J; Hanacek J; Capel F; Viguerie N; Richterova B; Bajzova M; Hejnova J; Stich V; Langin D
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2330-5. PubMed ID: 17405846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance.
    Hammarstedt A; Jansson PA; Wesslau C; Yang X; Smith U
    Biochem Biophys Res Commun; 2003 Feb; 301(2):578-82. PubMed ID: 12565902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue.
    Wu H; Wei L; Bao Y; Lu J; Huang P; Liu Y; Jia W; Xiang K
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E628-34. PubMed ID: 19088257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
    Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
    Miyazaki Y; Matsuda M; DeFronzo RA
    Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating Retinol-Binding Protein 4 Is Inversely Associated With Pancreatic β-Cell Function Across the Spectrum of Glycemia.
    Huang R; Yin S; Ye Y; Chen N; Luo S; Xia M; Zhao L
    Diabetes Care; 2020 Jun; 43(6):1258-1265. PubMed ID: 32265192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes.
    Kovacova Z; Tharp WG; Liu D; Wei W; Xie H; Collins S; Pratley RE
    Obesity (Silver Spring); 2016 Apr; 24(4):820-8. PubMed ID: 26887289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
    Varma V; Yao-Borengasser A; Rasouli N; Bodles AM; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; McGehee RE; Fried SK; Kern PA
    J Clin Endocrinol Metab; 2007 Feb; 92(2):666-72. PubMed ID: 17090638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
    Vu A; Kosmiski LA; Beitelshees AL; Prigeon R; Sidhom MS; Bredbeck B; Predhomme J; Deininger KM; Aquilante CL
    Pharmacotherapy; 2016 Mar; 36(3):252-62. PubMed ID: 26822630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone.
    Yao-Borengasser A; Varma V; Coker RH; Ranganathan G; Phanavanh B; Rasouli N; Kern PA
    Metabolism; 2011 Jul; 60(7):1012-20. PubMed ID: 21129760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parallel downregulation of retinol-binding protein-4 and adiponectin expression in subcutaneous adipose tissue of non-morbidly obese subjects.
    Broch M; Auguet MT; Ramírez R; Olona M; Aguilar C; Megia A; Alcaide MJ; Pastor R; Martínez S; Caubet E; Garcia-España A; Richart C
    Eur J Endocrinol; 2009 Jul; 161(1):87-94. PubMed ID: 19369430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.
    Kovacs P; Geyer M; Berndt J; Klöting N; Graham TE; Böttcher Y; Enigk B; Tönjes A; Schleinitz D; Schön MR; Kahn BB; Blüher M; Stumvoll M
    Diabetes; 2007 Dec; 56(12):3095-100. PubMed ID: 17728376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
    Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.